Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
Tempus AI announced that 13 abstracts were accepted for presentation at the ESMO Congress 2026, held October 23-27 in Madrid. The research spans clinicogenomic insights across solid tumors including prostate, breast, NSCLC, renal cell and gynecologic malignancies, leveraging Tempus' multimodal real-world data.
Key figures
- Abstracts accepted
- 13
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.